2 years ago-Biopharma Group

IDMP: Back on Track and Bearing Down with New Urgency – What Next?

Views: 123

As EMA renews its focus on ISO IDMP delivery, life sciences organisations targeting European markets must now step up their own measures to ensure they are compliant by 2021. Acknowledging the considerable task ahead of them, Siniša Belina of AMPLEXOR proposes a practical way forward.

Comments: 0

Your email address will not be published. Required fields are marked with *


Your Cart